A Phase II Study Evaluating the Efficacy of Enzalutamide & the Role of

See also
Status	Clinical Trial	Phase
Terminated	`NCT03323879` - Combined LDR Boost and HDR Whole Gland	Phase 1/Phase 2
Recruiting	`NCT05265988` - Multiparametric Assessment of Bone Response in mCRPC Patients Treated With Cabozantinib	Phase 2
Completed	`NCT01939743` - Efficacy of Diclofenac Suppository for Pain Control in Ultrasound Guided Biopsy of Prostate	Phase 2
Not yet recruiting	`NCT04985357` - Defining the Clinical Potential of Mass Response as a Biomarker for Patient Tumor Sensitivity to Drugs

See also

Status

Clinical Trial

Phase

Terminated

NCT03323879 - Combined LDR Boost and HDR Whole Gland

Phase 1/Phase 2

Recruiting

NCT05265988 - Multiparametric Assessment of Bone Response in mCRPC Patients Treated With Cabozantinib

Phase 2

Completed

NCT01939743 - Efficacy of Diclofenac Suppository for Pain Control in Ultrasound Guided Biopsy of Prostate

Phase 2

Not yet recruiting

NCT04985357 - Defining the Clinical Potential of Mass Response as a Biomarker for Patient Tumor Sensitivity to Drugs

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT03103724
Study type	Interventional
Source	Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Contact
Status	Completed
Phase	Phase 2
Start date	March 16, 2017
Completion date	April 23, 2021

A Phase II Study Evaluating the Efficacy of Enzalutamide and the Role of ARv7 in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients With Visceral Disease. — EXCALIBUR

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms